**Question:** Deficiency of Arylsulphatase is seen in

A. Gaucher disease
B. Tay-Sachs disease
C. Niemann-Pick disease
D. Krabbe disease

**Core Concept:**
Arylsulfatases are a group of lysosomal enzymes involved in the degradation of sulfated glycosaminoglycans (GAGs), particularly heparan sulfate and chondroitin sulfate. These enzymes play a crucial role in maintaining tissue homeostasis and preventing the accumulation of GAGs within lysosomes.

**Why the Correct Answer is Right:**
Deficiency in Arylsulfatase enzymes leads to the accumulation of sulfated GAGs, particularly dermatan sulfate and keratan sulfate, within lysosomes. This accumulation results in the destruction of lysosomes and, subsequently, cellular dysfunction and tissue damage. The accumulation of GAGs is more severe in neurons leading to the characteristic neuropathies seen in the lysosomal storage disorders.

Among the given options, Arylsulfatase deficiency is associated with Gaucher disease (GD). GD is a lysosomal storage disorder caused by mutations in the GBA1 gene, which encodes for glucocerebrosidase enzyme. The deficiency in glucocerebrosidase enzyme leads to the accumulation of glucosylceramide and glucocerebroside in macrophages, resulting in their dysfunction and tissue damage. The disease presents with symptoms involving the liver, spleen, and bone marrow.

**Why Each Wrong Option is Incorrect:**

A. Gaucher disease (as mentioned above) is the correct answer, not Gaucher disease variant (Gaucher disease type 2 or 3).
B. Tay-Sachs disease (HSAN type 1) is a neurodegenerative disorder caused by deficiency of hexosaminidase A enzyme, leading to accumulation of GM2 ganglioside in neurons and macrophages. The disease predominantly affects the central nervous system and results in progressive neurological deterioration.
C. Niemann-Pick disease is caused by deficiency of sphingomyelinase, leading to accumulation of sphingolipids (sphingomyelin and ceramide) in lysosomes, affecting multiple organs, particularly the liver and spleen.
D. Krabbe disease (also known as globoid cell leukodystrophy) is caused by deficiency of galactosidase alpha enzyme, leading to accumulation of galactosylceramide in neurons and macrophages. The disease primarily affects the central nervous system and results in progressive demyelination, leading to neurological symptoms.

**Clinical Pearl:**

Gaucher disease is the most common lysosomal storage disorder, affecting around 1 in 40,000 individuals worldwide. Most cases are due to mutations in the GBA1 gene, which codes for glucocerebrosidase enzyme. The deficiency in glucocerebrosidase leads to the accumulation of glucosylceramide and glucosylsphingosine in macrophages and neurons, causing damage to these cells and leading to the characteristic features of Gaucher disease, such as hepatosplenomegaly, bone pain, and osteopenia.